Lcb 2853 is a thromboxane A2 receptor antagonist. References: Depin JC, Vigié A, Chavernac G, Rousselot C, Lardy C, Guerrier D. Pharmacodynamics and antithrombotic effects after intravenous administration of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate. Arzneimittelforschung. 1994 Nov;44(11):1203-7. PubMed PMID: 7848332.

纯度：≥98%

CAS：141335-11-7